The European Commission is set to fund ten "European Partnerships" partnered with different industries with €10bn.
Cultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m.
DASbox® Mini Bioreactor System: In the Quality by Design (QbD) and Process Analytical Technology (PAT) era, the generation and validation of a large amount of data have become standard. Parallel bioreactor control systems offer the possibility to test and optimize different process parameters at the same time, thus saving time and resources.
Mads Krogsgaard Thomsen, CSO at Novo Nordisk, will take up the position as CEO of the Novo Nordisk Foundation effective from 1 March 2021.
Austrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses.
Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.
Swiss cancer vaccine specialist MaxiVAX SA has hired Minaris Regenerative Medicine GmbH to produce its cell therapy MVX-ONCO-2.
Pfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU.
A resesarch team headed by HepaRegeneriX Board Member Lars Zender has presented a new approach to treat hepatocellular carcinoma (HCC) by disturbing the lipid metabolism of tumour cells.
Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April.